556 related articles for article (PubMed ID: 15734729)
1. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.
Heinberg A; Kirkman L
Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157
[TBL] [Abstract][Full Text] [Related]
3. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
4. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
6. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
7. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.
Cortese JF; Caraballo A; Contreras CE; Plowe CV
J Infect Dis; 2002 Oct; 186(7):999-1006. PubMed ID: 12232841
[TBL] [Abstract][Full Text] [Related]
8. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum.
Wang P; Nirmalan N; Wang Q; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 May; 135(1):77-87. PubMed ID: 15287589
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
[TBL] [Abstract][Full Text] [Related]
10. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
11. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
12. Basis for antifolate action and resistance in malaria.
Yuthavong Y
Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
[TBL] [Abstract][Full Text] [Related]
14. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
16. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy.
Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
Trends Parasitol; 2005 Jun; 21(6):292-8. PubMed ID: 15922251
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system.
Auliff AM; Adams JH; O'Neil MT; Cheng Q
Antimicrob Agents Chemother; 2010 Sep; 54(9):3927-32. PubMed ID: 20566761
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance hampers our capacity to roll back malaria.
Olliaro P
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
20. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
